Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML. Cook JA, Lott L, Perry J, Eckel AM, et al. Blood 2024;144:581-585.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cook JA, Lott L, Perry J, Eckel AM, et al. Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML. Blood 2024;144:581-585.
PMID: 38749014